20 May 2013
Keywords: patent, expiries, stall, bph, drug, sales, during
Article | 29 September 2003
Patent expiries on drugs to treat benign prostatic hyperplasia will impact sales in all major markets (France, Germany, Italy, Japan, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 September 2003
© 2013 thepharmaletter.com